Rakuten Securities’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.83K Buy
80
+65
+433% +$6.28K ﹤0.01% 519
2026
Q2
$1.17K Sell
15
-55
-79% -$3.75K ﹤0.01% 712
2026
Q1
$4.52K Buy
70
+9
+15% +$634 ﹤0.01% 519
2025
Q4
$4.1K Sell
61
-15
-20% -$1.01K ﹤0.01% 547
2025
Q3
$5.57K Sell
76
-48
-39% -$3.19K ﹤0.01% 497
2025
Q2
$6.45K Buy
124
+111
+854% +$6.32K ﹤0.01% 468
2025
Q1
$830 Sell
13
-62
-83% -$3.6K ﹤0.01% 687
2024
Q4
$3.59K Sell
75
-14
-16% -$718 ﹤0.01% 509
2024
Q3
$5.09K Buy
+89
New +$5.1K ﹤0.01% 415

Other funds holding HALO

Rakuten Securities's HALO Position: Q3 2026 in Review

Rakuten Securities increased its Halozyme (HALO) stake by 433% in Q3 2026, buying an estimated $6.28K and bringing the position to 80 shares worth $8.83K. The position accounts for ﹤0.01% of the portfolio, ranked #519.

Rakuten Securities first reported a position in HALO in Q3 2024 and has held it in 9 quarters since. 774 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Rakuten Securities held 80 shares of Halozyme worth $8.83K as of Q3 2026.
  • Rakuten Securities bought 65 Halozyme shares in Q3 2026, an estimated $6.28K.
  • Halozyme made up ﹤0.01% of Rakuten Securities's portfolio in Q3 2026, its #519 holding.
  • Rakuten Securities first reported a position in Halozyme in Q3 2024 and has held it in 9 quarters since.
  • 774 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Rakuten Securities's 13F filing for Q3 2026, filed 2 Nov 2026.